Mechanisms linking obesity with cardiovascular disease (original) (raw)

• James, P. T., Rigby, N. & Leach, R. International Obesity Task Force. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur. J. Cardiovasc. Prev. Rehabil. 11, 3–8 (2004).
  Article PubMed Google Scholar
• Adams, K. F. et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N. Engl. J. Med. 355, 763–778 (2006).
  Article CAS PubMed Google Scholar
• Lakka, T. A., Lakka, H. M., Salonen, R., Kaplan, G. A. & Salonen, J. T. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis 154, 497–504 (2001).
  Article CAS PubMed Google Scholar
• Kenchaiah, S. et al. Obesity and the risk of heart failure. N. Engl. J. Med. 347, 305–313 (2002).
  Article PubMed Google Scholar
• Hu, F. B. et al. Adiposity as compared with physical activity in predicting mortality among women. N. Engl. J. Med. 351, 2694–2703 (2004).
  Article CAS PubMed Google Scholar
• Berenson, G. S. et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N. Engl. J. Med. 338, 1650–1656 (1998).
  Article CAS PubMed Google Scholar
• Olshansky, S. J. et al. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 352, 1138–1145 (2005).
  Article CAS PubMed Google Scholar
• Eckel, R. H., Kahn, R., Robertson, R. M. & Rizza, R. A. Preventing cardiovascular disease and diabetes. A call to action from the American Diabetes Association and the American Heart Association. Circulation 113, 2943–2946 (2006).
  Article PubMed Google Scholar
• Lau, D. C. W., Dhillon, B., Yan, H., Szmitko, P. E. & Verma, S. Adipokines: molecular links between obesity and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 288, H2031–H2041 (2005).
• Poirier, P. et al. American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113, 898–918 (2006).
  Article PubMed Google Scholar
• Peeters, A. et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann. Intern. Med. 138, 24–32 (2003).
  Article PubMed Google Scholar
• Stevens, J., Cai, J., Evenson, K. R. & Thomas, R. Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study. Am. J. Epidemiol. 156, 832–841 (2002).
  Article PubMed Google Scholar
• Pontiroli, A. E. et al. Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Eur. J. Endocrinol. 150, 195–200 (2004).
  Article CAS PubMed Google Scholar
• Blann, A. D., Steele, C. & McCollum, C. N. The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb. Res. 85, 433–438 (1997).
  Article CAS PubMed Google Scholar
• Iwashima, Y. et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension 45, 1094–1100 (2005).
  Article CAS PubMed Google Scholar
• Matsuzawa, Y. The metabolic syndrome and adipocytokines. FEBS Lett. 580, 2917–2921 (2006).
  Article CAS PubMed Google Scholar
• Liu, R., Mizuta, M. & Matsukura, S. The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes. J. Pharmacol. Exp. Ther. 310, 52–58 (2004).
  Article CAS PubMed Google Scholar
• Facchini, F. S., Hollenbeck, C. B., Jeppesen, J., Chen, Y. D. & Reaven, G. M. Insulin resistance and cigarette smoking. Lancet 339, 1128–1130 (1992).
  Article CAS PubMed Google Scholar
• van der Vaart, H., Postma, D. S., Timens, W. & Ten Hacken, N. H. T. Acute effects of cigarette smoking on inflammation and oxidative stress: a review. Thorax 59, 713–721 (2004).
  Article CAS PubMed Google Scholar
• Howard, B. V., Ruotolo, G. & Robbins, D. C. Obesity and dyslipidemia. Endocrinol. Metab. Clin. N. Am. 32, 855–867 (2003).
  Article CAS Google Scholar
• Yusuf, S. et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937–952 (2004).
  Article PubMed Google Scholar
• Gaudet, D. et al. Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. Circulation 97, 871–877 (1998).
  Article CAS PubMed Google Scholar
• Nicholls, S. J. et al. Effects of obesity on lipid-lowering, anti-inflammatory and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL study). Am. J. Cardiol. 97, 1553–1557 (2006).
  Article CAS PubMed Google Scholar
• Kwiterovich, P.O. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Am. J. Cardiol. 90, 30i–47i (2002).
  Article CAS PubMed Google Scholar
• Taskinen, M.R. Lipoprotein lipase in diabetes. Diabetes Metab. Rev. 3, 551–570 (1987).
  Article CAS PubMed Google Scholar
• Howard, B. V. et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler. Thromb. Vasc. Biol. 20, 830–835 (2000).
  Article CAS PubMed Google Scholar
• Chan, D. C., Watts, G. F., Redgrave, T. G., Mori, T. A. Barrett, P. H. R. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. Metabolism 51, 1041–1046 (2002).
  Article CAS PubMed Google Scholar
• Frenais, R. et al. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus. J. Clin. Endocrinol. Metab. 86, 1962–1967 (2001).
  CAS PubMed Google Scholar
• Mertens, I. & Van Gaal, L. F. New International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment panel III (NCEP-ATPIII) criteria and the involvement of hemostasis and fibrinolysis in the metabolic syndrome. J. Thromb. Haemost. 4, 1164–1166 (2006).
  Article CAS PubMed Google Scholar
• Blair, S. N. & Church, T. S. The fitness, obesity, and health equation: is physical activity the common denominator? J. Am. Med. Assoc. 292, 1232–1234 (2004).
  Article CAS Google Scholar
• Li, T. Y. et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 113, 499–506 (2006).
  Article PubMed Google Scholar
• Manson, J. E. et al. Body weight and mortality among women. N. Engl. J. Med. 333, 677–685 (1995).
  Article CAS PubMed Google Scholar
• Sandvik, L. et al. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. N. Engl. J. Med. 328, 533–537 (1993).
  Article CAS PubMed Google Scholar
• Nigro, J., Osman, N., Dart, A. M. & Little, P. J. Insulin resistance and atherosclerosis. Endocr. Rev. 27, 242–259 (2006).
  Article CAS PubMed Google Scholar
• Ferrannini, E. & Iozzo, P. Is insulin resistance atherogenic? A review of the evidence. Atheroscler. Suppl. 7, 5–10 (2006).
  Article CAS PubMed Google Scholar
• Smith, S. R. & Wilson, P. W. Free fatty acids and atherosclerosis — guilty or innocent? J. Clin. Endocrinol. Metab. 91, 2506–2508 (2006).
  Article CAS PubMed Google Scholar
• Pilz, S. et al. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J. Clin. Endocrinol. Metab. 91, 2542–2547 (2006).
  Article Google Scholar
• Graham, T. E. et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 354, 2552–2563 (2006).
  Article CAS PubMed Google Scholar
• Abel, E. D. et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729–733 (2001).
  Article ADS CAS Google Scholar
• Summers, S. A. et al. Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45, 42–72 (2006).
  Article CAS PubMed Google Scholar
• Rexrode, K. M. et al. Abdominal adiposity and coronary heart disease in women. J. Am. Med. Assoc. 280, 1843–1848 (1998).
  Article Google Scholar
• Després, J. P., Lemieux, I. & Prud'homme, D. Treatment of obesity: need to focus on high risk abdominally obese patients. Br. Med. J. 322, 716–720 (2001).
  Article Google Scholar
• Kuk, J. L. et al. Visceral fat is an independent predictor of all-cause mortality in men. Obesity 14, 336–342 (2006).
  Article PubMed Google Scholar
• Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796–1808 (2003).
  Article CAS PubMed Google Scholar
• Cancello, R. & Clement, K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 113, 1141–1147 (2006).
  Article CAS PubMed Google Scholar
• Bornstein, S. R. et al. Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes 49, 532–538 (2000).
  Article CAS PubMed Google Scholar
• Björntorp, P. 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10, 493–496 (1990).
  Article PubMed Google Scholar
• Yki-Jarvinen, H. & Westerbacka, J. The fatty liver and insulin resistance. Curr. Mol. Med. 5, 287–295 (2005).
  Article CAS PubMed Google Scholar
• Yusuf, S. et al. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366, 1640–1649 (2005).
  Article PubMed Google Scholar
• Montani, J. -P. et al. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int. J. Obesity 28, S58–S65 (2004).
  Article CAS Google Scholar
• Zhou, Y. T. et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl Acad. Sci. USA 97, 1784–1789 (2000).
  Article ADS CAS PubMed Google Scholar
• McGavock, J. M., Victor, R. G., Unger, R. H. & Szczepaniak, L. S. American College of Physicians and the American Physiological Society. Adiposity of the heart, revisited. Ann. Intern. Med. 144, 517–524 (2006).
  Article CAS PubMed Google Scholar
• Szczepaniak, L. S. et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn. Reson. Med. 49, 417–423 (2003).
  Article CAS PubMed Google Scholar
• Verlohren, S. et al. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 44, 271–276 (2004).
  Article CAS PubMed Google Scholar
• Arita, Y. et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105, 2893–2898 (2002).
  Article CAS PubMed Google Scholar
• Konstantinides, S., Schafer, K., Koschnick, S. & Loskutoff, D. J. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J. Clin. Invest. 108, 1533–1540 (2001).
  Article CAS PubMed Google Scholar
• Singhal, A. et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 106, 1919–1924 (2002).
  Article CAS PubMed Google Scholar
• Mertens, I., Considine, R. V., Van der Planken, M. & Van Gaal, L. F. Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin? Eur. J. Endocrinol. 155, 477–484 (2006).
  Article CAS PubMed Google Scholar
• Kumada, M. et al. Adiponectin specifically increases tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 109, 2046–2049 (2004).
  Article CAS PubMed Google Scholar
• Kobayashi, H. et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 94, e27–e31 (2004).
  Article CAS PubMed Google Scholar
• Ouchi, N. et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42, 231–232 (2003).
  Article CAS PubMed Google Scholar
• Fukuhara, A. et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426–430 (2005).
  Article ADS CAS PubMed Google Scholar
• Haider, D. G. et al. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49, 1909–1914 (2006).
  Article CAS PubMed Google Scholar
• Mertens, I. & Van Gaal, L. F. Obesity, haemostasis and the fibrinolytic system. Obes. Rev. 3, 85–101 (2002).
  Article CAS PubMed Google Scholar
• Bastelica, D. et al. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler. Thromb. Vasc. Biol. 22, 173–178 (2002).
  Article CAS PubMed Google Scholar
• Alessi, M. C. et al. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler. Thromb. Vasc. Biol. 23, 1262–1268 (2003).
  Article Google Scholar
• Alessi, M. C. & Juhan-Vague, I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler. Thromb. Vasc. Biol. 26, 200–207 (2006).
  Article Google Scholar
• Esmon, C. T. The interactions between inflammation and coagulation. Br. J. Haematol. 131, 417–430 (2005).
  Article CAS PubMed Google Scholar
• Hanley, A. J. et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 53, 1773–1781 (2004).
  Article CAS PubMed Google Scholar
• Devaraj, S., Xu, D. Y. & Jialal, I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 107, 398–404 (2003).
  Article CAS PubMed Google Scholar
• Ceriello, A. & Motz, E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24, 816–823 (2004).
  Article CAS PubMed Google Scholar
• Holvoet, P. et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging and body composition cohort. Diabetes 53, 1068–1073 (2004).
  Article CAS PubMed Google Scholar
• Maddux, B. A. et al. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of alpha-lipoic acid. Diabetes 50, 404–410 (2001).
  Article CAS PubMed Google Scholar
• Esposito, K. et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106, 2067–2072 (2002).
  Article CAS PubMed Google Scholar
• Tripathy, D. et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52, 2882–2887 (2003).
  Article CAS PubMed Google Scholar
• Sattar, N. et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes 53, 2855–2860 (2004).
  Article CAS PubMed Google Scholar
• Libby, P., Ridker, P. & Maseri, A. Inflammation and atherosclerosis. Circulation 105, 1135–1143 (2002).
  Article CAS PubMed Google Scholar
• Berg, A. H., Scherer, P. E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 96, 939–949 (2005).
  Article CAS PubMed Google Scholar
• Berg, A. H., Lin, Y., Lisanti, M. P. & Scherer, P. E. Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. Am. J. Physiol. Endocrinol. Metab. 287, E1178–E1188 (2004).
  Article CAS PubMed Google Scholar
• Rutter, M. K. et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107, 448–454 (2003).
  Article CAS PubMed Google Scholar
• Young, M. E. et al. Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms. Circulation 105, 1861–1870 (2002).
  Article CAS PubMed Google Scholar